Expression of programmed cell death 4 (PDCD4) related to tumor differentiation in human cancers of digestive system

Chinese Journal of Cancer Prevention and Treatment

Volumn 14, Issue 4, 2007, Pages 249-253

  Ma, Gang ^a   Zhang, Hao ^a   Dong, Ming ^a   Zheng, Xin Yu ^a   Ozaki, Iwata ^b   Matsuhashi, Sachiko ^b   Guo, Ke Jian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b SAGA UNIVERSITY   (Japan)

Author keywords

Digestive system neoplasms pathology; Immunohistochemistry; Neoplasm proteins analytical

Indexed keywords

ONCOPROTEIN; PARAFFIN; PROGRAMMED CELL DEATH PROTEIN 4; PROTEIN PDCD4; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; APOPTOSIS; ARTICLE; CANCER STAGING; CELL DIFFERENTIATION; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DIGESTIVE SYSTEM CANCER; DOWN REGULATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SEX DIFFERENCE; STOMACH CANCER; TUMOR DIFFERENTIATION; UPREGULATION; WESTERN BLOTTING;

EID: 77953415711     PISSN: 16735269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Nguyen D X, McCance D J. Role of the retinoblastoma tumor suppressor protein in cellular differentiation[J]. J Cell Biochem, 2005,94(5): 870-879.
2. Chen Y, Knosel T, Kristiansen G, et al. Loss of PDCD4 expression in human lung cancer correlates with tumor progression and prognosis[J]. J Pathol,2003,200(5): 640-646.
3. Yoshinaga H, Matsuhashi S, Fujiyama C, et al. Novel human PDCD4 (H731) gene expressed in proliferative cells is expressed in the small duct epithelial cells of the breast as revealed by an anti-H731 antibody [J]. Pathol Int, 1999, 49(12): 1067-1077.
4. Cmarik J L, Min H, Hegamyer G, et al. Differentially expressed protein PDCD4 inhibits tumor promoter-induced neoplastic transformation[J]. Proc Natl Acad Sci USA, 1999, 96(24): 14037-14042.
5. Yang H S, Knies J L, Stark C, et al. Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation[J]. Oncogene, 2003, 22(24): 3712-3720.
6. Yang H S, Jansen A P, Nair R, et al. A novel transformation suppressor, PDCD4, inhibits AP-1 transaction but not NF-κB or ODC transactivation[J]. Oncogene, 2001, 20(6): 669-676.
7. Young M R, Yang H S, Colburn N H. Promising molecular targets for cancer prevention, AP-1, NF-kappa B and Pdcd4[J]. Trends Mol Med, 2003, 9(1): 36-41.
8. Yang H S, Matthews C P, Clair T, et al. Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion[J]. Mol Cell Biol,2006,26(4): 1297-1306.
9. Jansen A P, Camalier CE, Colburn N H. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis[J]. Cancer Res,2005,65(14): 6034-6041.
10. Yang H S, Jansen A P, Komar A A, et al. The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation[J]. Mol Cell Biol, 2003,23(1): 26-37.
11. Yang H S, Cho M H, Zakowicz H, et al. A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A[J]. Mol Cell Biol,2004,24(9): 3894-3906.
12. Shibahara K, Asano M, Ishida Y, et al. Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death [J]. Gene,1995,166(2): 297-301.
13. Afonja O, Juste D, Das S, et al. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis[J]. Oncogene,2004,23(49): 8135-8145.
14. Zhang H, Ozaki I, Mizuta T, et al. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma [J]. Oncogene, 2006, 25(45): 6101-6112.
15. Roth W, Reed J C. Apoptosis and cancer: when BAX is TRAI-Ling away[J]. Nat Med, 2002,8(3): 216-218.
16. Jansen A P, Camalier C E, Stark C, et al. Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity[J]. Mol Cancer Ther, 2004, 3(2): 103-110.